-
1
-
-
33845232634
-
10 deficiency due to decaprenyl diphosphote synthase subunit 2 (PDSS2) mutations
-
DOI 10.1086/510023
-
Lopez LC, Schuelke M, Quinzii CM, Kanki T, Rodenburg RJ, Naini A, et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 2006; 79: 1125-1129. (Pubitemid 44853484)
-
(2006)
American Journal of Human Genetics
, vol.79
, Issue.6
, pp. 1125-1129
-
-
Lopez, L.C.1
Schuelke, M.2
Quinzii, C.M.3
Kanki, T.4
Rodenburg, R.J.T.5
Naini, A.6
DiMauro, S.7
Hirano, M.8
-
2
-
-
27644497075
-
Characterization of solanesyl and decaprenyl diphosphate synthases in mice and humans
-
DOI 10.1111/j.1742-4658.2005.04956.x
-
Saiki R, Nagata A, Kainou T, Matsuda H, Kawamukai M. Characterization of solanesyl and decaprenyl diphosphate synthases in mice and humans. FEBS J 2005; 272:5606-5622. (Pubitemid 41579420)
-
(2005)
FEBS Journal
, vol.272
, Issue.21
, pp. 5606-5622
-
-
Saiki, R.1
Nagata, A.2
Kainou, T.3
Matsuda, H.4
Kawamukai, M.5
-
3
-
-
79960083220
-
Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice
-
Falk MJ, Polyak E, Zhang Z, Peng M, King R, Maltzman JS, et al. Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice. EMBO Mol Med 2011; 3:4 10-427.
-
(2011)
EMBO Mol Med
, vol.3
, pp. 410-427
-
-
Falk, M.J.1
Polyak, E.2
Zhang, Z.3
Peng, M.4
King, R.5
Maltzman, J.S.6
-
4
-
-
77954597034
-
Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome
-
Machuca E, Benoit G, Nevo F, Tete MJ, Gribouval O, Pawtowski A, et al. Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome. J Am Soc Nephrol 2010; 21:1209-1217.
-
(2010)
J Am Soc Nephrol
, vol.21
, pp. 1209-1217
-
-
Machuca, E.1
Benoit, G.2
Nevo, F.3
Tete, M.J.4
Gribouval, O.5
Pawtowski, A.6
-
5
-
-
43249118592
-
Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease
-
Peng M, Falk MJ, Haase VH, King R, Polyak E, Selak M, et al. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease. PLoS Genet 2008; 4:e1000 061.
-
(2008)
PLoS Genet
, vol.4
-
-
Peng, M.1
Falk, M.J.2
Haase, V.H.3
King, R.4
Polyak, E.5
Selak, M.6
-
6
-
-
84858004895
-
Parkinson's disease-like neuromuscular defects occur in prenyl diphosphate synthase subunit 2 (Pdss2) mutant mice
-
Ziegler CG, Peng M, Falk MJ, Polyak E, Tsika E, Ischiropoulos H, et al. Parkinson's disease-like neuromuscular defects occur in prenyl diphosphate synthase subunit 2 (Pdss2) mutant mice. Mitochondrion 2012; 12:248-257.
-
(2012)
Mitochondrion
, vol.12
, pp. 248-257
-
-
Ziegler, C.G.1
Peng, M.2
Falk, M.J.3
Polyak, E.4
Tsika, E.5
Ischiropoulos, H.6
-
7
-
-
81955161104
-
Cerebellar defects in Pdss2 conditional knockout mice during embryonic development and in adulthood
-
Lu S, Lu LY, Liu MF, Yuan QJ, Sham MH, Guan XY, Huang JD. Cerebellar defects in Pdss2 conditional knockout mice during embryonic development and in adulthood. Neurob iol Dis 2012; 45:219-233.
-
(2012)
Neurob Iol Dis
, vol.45
, pp. 219-233
-
-
Lu, S.1
Lu, L.Y.2
Liu, M.F.3
Yuan, Q.J.4
Sham, M.H.5
Guan, X.Y.6
Huang, J.D.7
-
8
-
-
84863874490
-
Update on clinical aspects and treatment of selected vitaminresponsive disorders II (riboflavin and CoQ(10)
-
Horvath R. Update on clinical aspects and treatment of selected vitaminresponsive disorders II (riboflavin and CoQ(10)). J Inherit Metab Dis 2012; 35:679-687.
-
(2012)
J Inherit Metab Dis
, vol.35
, pp. 679-687
-
-
Horvath, R.1
-
9
-
-
0036539554
-
Characterization of a complex chromosome rearrangement involving 6q in a melanoma cell line by chromosome microdissection
-
DOI 10.1016/S0165-4608(01)00608-2, PII S0165460801006082
-
Guan XY, Zhang HE, Zhou H, Sham JS, Fung JM, Trent JM. Characterization of a complex chromosome rearrangement involving 6q in a melanoma cell line by chromosome microdissection. Cancer Genet Cytogenet 2002; 134:65-70. (Pubitemid 34462112)
-
(2002)
Cancer Genetics and Cytogenetics
, vol.134
, Issue.1
, pp. 65-70
-
-
Guan, X.-Y.1
Zhang, H.-E.2
Zhou, H.3
Sham, J.S.T.4
Fung, J.M.-W.5
Trent, J.M.6
-
10
-
-
59449083118
-
Anticancer activity of PDSS2, prenyl diphosphate synthase, subunit 2, in gastric cancer tissue and the SGC7901 cell lin e
-
Chen P, Zhao SH, Chu YL, Xu K, Zhu L, Wu Y, et al. Anticancer activity of PDSS2, prenyl diphosphate synthase, subunit 2, in gastric cancer tissue and the SGC7901 cell lin e. Anticancer Drugs 2009; 20:141-148.
-
(2009)
Anticancer Drugs
, vol.20
, pp. 141-148
-
-
Chen, P.1
Zhao, S.H.2
Chu, Y.L.3
Xu, K.4
Zhu, L.5
Wu, Y.6
-
11
-
-
61349098014
-
Identification and characterization of a novel melanoma tumor suppressor gene on h uman chromosome 6q21
-
Fung JM, Smith R, Brown MA, Lau SH, Xie D, Lau GK, Guan XY. Identification and characterization of a novel melanoma tumor suppressor gene on h uman chromosome 6q21. Clin Cancer Res 2009; 15:797-803.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 797-803
-
-
Fung, J.M.1
Smith, R.2
Brown, M.A.3
Lau, S.H.4
Xie, D.5
Lau, G.K.6
Guan, X.Y.7
-
12
-
-
0031971078
-
Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types
-
DOI 10.1002/(SICI)1098-2264(199804)21:4<308::AID-GCC4>3.0.CO;2-2
-
Virmani AK, Fong KM, Kodagoda D, McIntire D, Hung J, Tonk V, et al. Allelotyping demonstrates common and distinct patterns o f chromosomal loss in human lung cancer types. Genes Chromosomes Cancer 1998; 21:308-319. (Pubitemid 28165038)
-
(1998)
Genes Chromosomes and Cancer
, vol.21
, Issue.4
, pp. 308-319
-
-
Virmani, A.K.1
Fong, K.M.2
Kodagoda, D.3
McIntire, D.4
Hung, J.5
Tonk, V.6
Minna, J.D.7
Gazdar, A.F.8
-
13
-
-
77950241825
-
A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers
-
Amos CI, Pinney SM, Li Y, Kupert E, Lee J, de Andrade MA, et al. A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers. Cancer Res 2010; 70:2359-2367.
-
(2010)
Cancer Res
, vol.70
, pp. 2359-2367
-
-
Amos, C.I.1
Pinney, S.M.2
Li, Y.3
Kupert, E.4
Lee, J.5
De Andrade, M.A.6
-
14
-
-
0028270326
-
Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer
-
Merlo A, Gabrielson E, Mabry M, Vollmer R, Baylin SB, Sidransky D. Homo zygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res 1994; 54:2322-2326. (Pubitemid 24138718)
-
(1994)
Cancer Research
, vol.54
, Issue.9
, pp. 2322-2326
-
-
Merlo, A.1
Gabrielson, E.2
Mabry, M.3
Vollmer, R.4
Baylin, S.B.5
Sidransky, D.6
-
15
-
-
0035231780
-
Genescan analysis of the loss of heterozygosity on the long arm of chromosome 6 in non-small cell lung cancer
-
Gao H,Wang Q,Wang BQ,Yan C.H.,Wang SF,Wang BC,et al, Genescan analysis of the loss of heterozygosity on the long arm of chromosome 6 in non-small cell lung cancer,Yi Chuan Xue Bao,2001,28,903-910.
-
(2001)
Yi Chuan Xue Bao
, vol.28
, pp. 903-910
-
-
Gao, H.1
Wang, Q.2
Wang, B.Q.3
Yan, C.H.4
Wang, S.F.5
Wang, B.C.6
-
16
-
-
84875805799
-
Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer
-
Chen P, Yu J, Knecht J, Chen Q. Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer. Cancer Epidemiol 2013; 37:166-171.
-
(2013)
Cancer Epidemiol
, vol.37
, pp. 166-171
-
-
Chen, P.1
Yu, J.2
Knecht, J.3
Chen, Q.4
-
17
-
-
0023130372
-
Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
-
Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation o f a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47:936-942. (Pubitemid 17027905)
-
(1987)
Cancer Research
, vol.47
, Issue.4
, pp. 936-942
-
-
Carmichael, J.1
DeGraff, W.G.2
Gazdar, A.F.3
-
18
-
-
0034609764
-
Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC
-
Kusano H, Shimizu S, Koya RC, Fujita H, Kamada S, Kuzumaki N, Tsujimoto Y. Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene 2000; 19:4807-4814.
-
(2000)
Oncogene
, vol.19
, pp. 4807-4814
-
-
Kusano, H.1
Shimizu, S.2
Koya, R.C.3
Fujita, H.4
Kamada, S.5
Kuzumaki, N.6
Tsujimoto, Y.7
-
19
-
-
0034685808
-
Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release
-
DOI 10.1074/jbc.275.20.15343
-
Koya RC, Fujita H, Shimizu S, Ohtsu M, Takimot o M, Tsujimoto Y, Kuzumaki N. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J Biol Chem 2000; 275:15343-15349. (Pubitemid 30337262)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.20
, pp. 15343-15349
-
-
Koya, R.C.1
Fujita, H.2
Shimizu, S.3
Ohtsu, M.4
Takimoto, M.5
Tsujimoto, Y.6
Kuzumaki, N.7
-
21
-
-
84885054761
-
Nm23-H1 binds gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis
-
Marino N, Marshall JC, Collins JW, Zhou M, Qian Y, Veenstra T, Steeg PS. Nm23-H1 binds gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis. Cancer Res 2013; 73:5949-5962.
-
(2013)
Cancer Res
, vol.73
, pp. 5949-5962
-
-
Marino, N.1
Marshall, J.C.2
Collins, J.W.3
Zhou, M.4
Qian, Y.5
Veenstra, T.6
Steeg, P.S.7
-
22
-
-
84857356486
-
Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer
-
Tsai MH,Wu CC, Peng PH, Liang Y, Hsiao YC, Chien KY, et al. Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer. J Mol Med (Berl) 2012; 90:187-2 00.
-
(2012)
J Mol Med (Berl
, vol.90
, pp. 187-200
-
-
Tsai, M.H.1
Wu, C.C.2
Peng, P.H.3
Liang, Y.4
Hsiao, Y.C.5
Chien, K.Y.6
-
23
-
-
84855769823
-
Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and Topo-II proteins in nonsmall cell lung cancer
-
Zhu WY, Hunag YY, Liu XG, He JY, Chen DD, Zeng F, et al. Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and Topo-II proteins in nonsmall cell lung cancer. Anat Rec (Hoboken) 2012; 295:208-214.
-
(2012)
Anat Rec (Hoboken
, vol.295
, pp. 208-214
-
-
Zhu, W.Y.1
Hunag, Y.Y.2
Liu, X.G.3
He, J.Y.4
Chen, D.D.5
Zeng, F.6
-
25
-
-
34248194299
-
The antioxidant role of coenzyme Q
-
DOI 10.1016/j.mito.2007.02.006, PII S1567724907000517, The Roled of Coenzyme Q in Cellular Metabolism: Current Biological and Clinical Aspects
-
Bentinger M, Brismar K, Da llner G. The antioxidant role of coenzyme Q. Mitochondrion 2007; 7 (Suppl):S41-S50. (Pubitemid 46712227)
-
(2007)
Mitochondrion
, vol.7
, Issue.SUPPL.
-
-
Bentinger, M.1
Brismar, K.2
Dallner, G.3
-
26
-
-
77957844254
-
Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency
-
Quinzii CM, Lopez LC, Gilkerson RW, Dorado B, Coku J, Naini AB, et al. Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J 2010; 24:3733-3743.
-
(2010)
FASEB J
, vol.24
, pp. 3733-3743
-
-
Quinzii, C.M.1
Lopez, L.C.2
Gilkerson, R.W.3
Dorado, B.4
Coku, J.5
Naini, A.B.6
-
27
-
-
0029833069
-
Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma
-
Picardo M, Grammatico P, Roccella F, Roccella M, Grandinetti M, Del Porto G, Passi S. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma . J Invest Dermatol 1996; 107:322-326. (Pubitemid 26284337)
-
(1996)
Journal of Investigative Dermatology
, vol.107
, Issue.3
, pp. 322-326
-
-
Picardo, M.1
Grammatico, P.2
Roccella, F.3
Roccella, M.4
Grandinetri, M.5
Del Porto, G.6
Passi, S.7
-
28
-
-
0033849560
-
Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients
-
DOI 10.1016/S0009-9120(00)00067-9, PII S0009912000000679
-
Portakal O, Ozkaya O, Erden Inal M, Bozan B, Kosan M, Sayek I. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer pat ients. Clin Biochem 2000; 33:279-284. (Pubitemid 30670179)
-
(2000)
Clinical Biochemistry
, vol.33
, Issue.4
, pp. 279-284
-
-
Portakal, O.1
Ozkaya, O.2
Erden Inal, M.3
Bozan, B.4
Kosan, M.5
Sayek, I.6
-
29
-
-
33745600112
-
1 on eukaryotic DNA polymerase γ and DNA topoisomerase II activities on the growth of a human cancer cell line
-
DOI 10.1111/j.1349-7006.2006.00236.x
-
Yonezawa Y, Kuriyama I, Fukuoh A, Muta T, Kang D, Takemura M, et al. Inhibitory effect of coenzyme Q on eukaryotic DNA polymerase gamma and DN A topoisomerase II activities on the growth of a human cancer cell line. Cancer Sci 2006; 97:716-723. (Pubitemid 43983783)
-
(2006)
Cancer Science
, vol.97
, Issue.8
, pp. 716-723
-
-
Yonezawa, Y.1
Kuriyama, I.2
Fukuoh, A.3
Muta, T.4
Kang, D.5
Takemura, M.6
Kato, I.7
Yoshida, H.8
Mizushina, Y.9
-
30
-
-
19544371393
-
Coenzyme Q10 for prevention of anthracycline-induced cardiotoxicity
-
DOI 10.1177/1534735405276191
-
Conklin KA. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr Cancer Ther 2005; 4:110-130. (Pubitemid 40731561)
-
(2005)
Integrative Cancer Therapies
, vol.4
, Issue.2
, pp. 110-130
-
-
Conklin, K.A.1
-
32
-
-
19544393409
-
Protective effect of coenzyme q10 on adriamycin toxicity and increase of antitumor effects of adriamycin by coenzyme Q10
-
In: Yamamura Y, Folkers K, Ito Y, editors Amsterdam, the Netherlands: Elsevier/North-Holland Biomedical Press
-
Yamanaka N, Kato T, Nishida K, Fujikawa T, Fukushima M, Ota K. Protective effect of coenzyme Q10 on Adriamycin toxicity and increase of antitumor effects of Adriamycin by coenzyme Q10. In: Yamamura Y, Folkers K, Ito Y, editors. Biomedic al and clinical aspects of coenzyme Q. Amsterdam, the Netherlands: Elsevier/North-Holland Biomedical Press; 1980. pp. 213-224.
-
(1980)
Biomedic Al and Clinical Aspects of Coenzyme Q
, pp. 213-224
-
-
Yamanaka, N.1
Kato, T.2
Nishida, K.3
Fujikawa, T.4
Fukushima, M.5
Ota, K.6
-
33
-
-
84870457971
-
Lack of effect of coenzyme q10 on doxorubicin cytotoxicity in breast cancer cell cultures
-
Greenlee H, Shaw J, Lau YK, Naini A, Maurer M. Lack of effect of coenzyme q10 on doxorubicin cytotoxicity in breast cancer cell cultures. Integr Cancer Ther 2012; 11:243-250.
-
(2012)
Integr Cancer Ther
, vol.11
, pp. 243-250
-
-
Greenlee, H.1
Shaw, J.2
Lau, Y.K.3
Naini, A.4
Maurer, M.5
-
34
-
-
0018143383
-
Adriamycin cardiotoxicity: Early detection by systolic time interval and possible prevention by coenzyme Q10
-
Cortes EP, Gupta M, Chou C, Amin VC, Folkers K. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10. Cancer Treat Rep 1978; 62:887-891. (Pubitemid 8377883)
-
(1978)
Cancer Treatment Reports
, vol.62
, Issue.6
, pp. 887-891
-
-
Cortes, E.P.1
Gupta, M.2
Chou, C.3
-
35
-
-
0021227758
-
10 against the side-effects of anthracycline antineoplastic agents
-
Tsubaki K, Horiuchi A, Kitani T, Taniguchi N, Masaoka T, Shibata H, et al. Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents. Gan To Kagaku Ryoho 1984; 11:1420-1427. (Pubitemid 14070193)
-
(1984)
Japanese Journal of Cancer and Chemotherapy
, vol.11
, Issue.7
, pp. 1420-1427
-
-
Tsubaki, K.1
Horiuchi, A.2
Kitani, T.3
-
36
-
-
0020334080
-
Clinical and pharmacologic investigation of the effects of α-tocopherol on adriamycin cardiotoxicity
-
Legha SS,Wang YM,Mackay B,Ewer M,Hortobagyi GN.Benjamin RS,Ali MK, Clinical and pharmacologic investigation of the effects of alphatocopherol on adriamycin cardiotoxicity,Ann N YAcad Sci,1982,393,411-418. (Pubitemid 13206927)
-
(1982)
Annals of the New York Academy of Sciences
, vol.393
, pp. 411-418
-
-
Legha, S.S.1
Wang, Y.M.2
Mackay, B.3
-
37
-
-
0021058948
-
Clinical evaluation by double blind method for protective effects to adverse reactions of anthracycline antibiotics: Especially hair loss
-
Akihama T, Nakamoto Y, Shindo T, Nakayama Y, Miura A. Protective effects of coenzyme Q10 on the adverse reactions of anthracycline antibiotics: using double blind method-with special reference to hair lo ss. Gan To Kagaku Ryoho 1983; 10:2125- 2129. (Pubitemid 14200617)
-
(1983)
Japanese Journal of Cancer and Chemotherapy
, vol.10
, Issue.10
, pp. 2125-2129
-
-
Akihama, T.1
Nakamoto, Y.2
Shindo, T.3
|